If you or a loved one has been diagnosed with open-angle glaucoma (OAG) or ocular hypertension (OHT), a DURYSTA™ implant may be a viable option. Keep reading to learn all about how DURYSTA™ can help you or your loved one!
What is DURYSTA™?
DURYSTA™ is an FDA-approved, sustained-release, biodegradable implant available at The Eye Center in Columbia. It’s meant to reduce intraocular pressure in those with open-angle glaucoma and ocular hypertension who have trouble administering their daily eye drop medication.
This implant takes minutes for our ophthalmologists to install, and provides patients with relief for up to 6-12 months. A single dose of DURYSTA™ is loaded into an applicator and directly administered to the anterior chamber of the eye during a painless procedure at The Eye Center.
Studies have shown that DURYSTA™ can lower IOP in patients by up to 33% when administered by an ophthalmologist. It should only be implanted once per eye and will release preservative-free medication over a sustained period of time, eliminating the need for eye drops.
DURYSTA™ Can Help Patients Who Struggle with Eye Drops
Many OAG and OHT patients report difficulties with properly administering their medicated eye drops. Doing so may be difficult for people with:
Unfortunately, failure to regularly administer eye drops prescribed by a doctor may place patients at a greater risk for vision loss. Thankfully, DURYSTA™ provides relief from IOP symptoms and gives both patients and their doctors confidence that the condition is under control.
While DURYSTA™ is suitable for many OAG and OHT patients who have been diagnosed by an ophthalmologist, some patients should avoid it due to the high risk of contradictory results. DURYSTA™ is not recommended for anyone with:
You can learn more about DURYSTA™ by contacting our professionals at The Eye Center.
About The Eye Center
The Eye Center is the leading refractive practice in South Carolina, providing full service eye care and specializing in Refractive Surgery – Lasik, AST, PRK, PRELEX, as well as Corneal Transplant and Cataract Surgery.